MedTrace Logo

Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer

NCT03192592 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-06-28

No results posted yet for this study

Summary

Safety and effectiveness evaluation of a new moisturizer formulation with antioxidant, anti-inflammatory and anti-microbial effects in the prevention of diabetics dry skin and complications.

Conditions

  • Skin Diseases, Metabolic
  • Skin Care

Interventions

OTHER

Body moisturizer

Daily body moisturizer application for skin protection and barrier.

Sponsors & Collaborators

  • Allergisa Pesquisa Dermato-Cosmetica LTDA

    collaborator INDUSTRY

  • ANS Pharma

    lead INDUSTRY

Principal Investigators

  • Lucas O. Guerra, MSc · Allergisa Pesquisa Dermato-Cosmetica LTDA

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-02
Primary Completion
2017-06-26
Completion
2017-07-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03192592 on ClinicalTrials.gov